Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
William A Hawkins is Director at Biogen. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 11, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , William A Hawkins reported holding 10,365 shares of Biogen (BIIB), worth about $2.61M at the last close of $251 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Biogen BIIB | 10,365 | 10K direct | $251 | $2.61M | Jun 9, 2026 |
Is this William A Hawkins’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
William A Hawkins bought shares on the open market in 2023, and has not bought since 2023.
William A Hawkins reported 2 open-market purchases and 0 sales since 2023; purchases in 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $235K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
BiogenBIIB
Jun 9, 20261,505disclosed Jun 11
DetailsOfficial recordOn the latest SEC Form 4, dated Jun 9, 2026, William A Hawkins reported holding 10,365 shares of Biogen (BIIB). At the last close of $251 on Nov 18, 2026, that is about $2.61M. This is the stake disclosed in filings, not a net worth.
No public filing gives William A Hawkins's net worth. What SEC Form 4 shows is the stock stake: 10,365 shares of Biogen (BIIB), about $2.61M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
William A Hawkins bought shares on the open market in 2023, and has not bought since 2023.
In SEC filings since 2023: the latest open-market purchase is from 2023; no open-market sale is on record.
Bioventus (BVS), from 2023 to 2023: 2 purchases and 0 sales.
William A Hawkins reported 2 open-market purchases and 0 sales here, 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.